Asker Healthcare Group AB
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Asker Healthcare Group AB (I88) - Total Liabilities
Latest total liabilities as of June 2025: €8.78 Billion EUR
Based on the latest financial reports, Asker Healthcare Group AB (I88) has total liabilities worth €8.78 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Asker Healthcare Group AB - Total Liabilities Trend (2022–2024)
This chart illustrates how Asker Healthcare Group AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Asker Healthcare Group AB Competitors by Total Liabilities
The table below lists competitors of Asker Healthcare Group AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen International Holdings Limited
F:SXYA
|
Germany | €84.57 Billion |
|
Industrial & Infrastructure Fund Investment Corp
F:2ES
|
Germany | €309.01 Billion |
|
Zotye Automobile Co Ltd
SHE:000980
|
China | CN¥3.35 Billion |
|
IperionX Limited American Depositary Share
NASDAQ:IPX
|
USA | $12.59 Million |
|
Bank First National Corp
NASDAQ:BFC
|
USA | $3.88 Billion |
|
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572
|
China | CN¥2.97 Billion |
|
HomeCo Daily Needs REIT
PINK:HDNRF
|
USA | $1.89 Billion |
Liability Composition Analysis (2022–2024)
This chart breaks down Asker Healthcare Group AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Asker Healthcare Group AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Asker Healthcare Group AB (2022–2024)
The table below shows the annual total liabilities of Asker Healthcare Group AB from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €9.62 Billion | +16.07% |
| 2023-12-31 | €8.29 Billion | +11.31% |
| 2022-12-31 | €7.44 Billion | -- |